A股異動 | 惠而浦跌逾5% 澄清不涉及C2M業務
格隆匯4月9日丨此前連續三個交易日漲停的惠而浦(600983.S)現報6.79元,跌5.3%,暫成交3.4億元,最新總市值52億元。惠而浦昨晚發風險提示公告稱,有關公司為市場傳聞的C2M(根據單個消費者需求進行差異化產品定製)概念股一事,説明如下:目前公司不涉及上述C2M業務。2019年三季度,公司線上業務收入共計2.53億元,佔營業收入比例為6.2%,佔比較低。該線上業務亦與上述C2M業務或相關模式無關。此外據悉,惠而浦將於4月30日發佈財報,此前公司預計2019年度將實現歸屬於上市公司股東的淨利潤虧損2.8億元到虧損4.2億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.